From the *Department of Surgery, Clinical Research, Westchester Medical Center, Valhalla, NY; †Clinical Medicine, Weill Cornell Medical College, Doha, Qatar; ‡Department of Medicine, New York Medical College/Westchester Medical Center, Valhalla, NY; §Department of Surgery, New York Medical College/Westchester Medical Center, Valhalla, NY; and ¶Department of Surgery, Trauma & Vascular Surgery, Hamad General Hospital, Qatar.
Cardiol Rev. 2017 Nov/Dec;25(6):279-288. doi: 10.1097/CRD.0000000000000167.
The cardiovascular manifestations associated with nontraumatic head disorders are commonly known. Similar manifestations have been reported in patients with traumatic brain injury (TBI); however, the underlying mechanisms and impact on the patient's clinical outcomes are not well explored. The neurocardiac axis theory and neurogenic stunned myocardium phenomenon could partly explain the brain-heart link and interactions and can thus pave the way to a better understanding and management of TBI. Several observational retrospective studies have shown a promising role for beta-adrenergic blockers in patients with TBI in reducing the overall TBI-related mortality. However, several questions remain to be answered in clinical randomized-controlled trials, including population selection, beta blocker type, dosage, timing, and duration of therapy, while maintaining the optimal mean arterial pressure and cerebral perfusion pressure in patients with TBI.
与非创伤性头部疾病相关的心血管表现是众所周知的。在创伤性脑损伤(TBI)患者中也有类似的表现;然而,其潜在机制及其对患者临床结局的影响尚未得到充分探讨。神经心脏轴理论和神经源性心肌顿抑现象可以部分解释脑-心联系和相互作用,从而为更好地理解和管理 TBI 铺平道路。几项观察性回顾性研究表明,β-肾上腺素能阻滞剂在 TBI 患者中具有降低整体 TBI 相关死亡率的有前途的作用。然而,在临床随机对照试验中仍有几个问题需要解答,包括人群选择、β受体阻滞剂类型、剂量、时机和治疗持续时间,同时保持 TBI 患者的最佳平均动脉压和脑灌注压。